Stock Price Movement and Market Context
On 27 March 2026, Meghmani Organics Ltd’s stock price fell by 3.73% to close at Rs 40.25, touching an intraday low of Rs 40.12. This price is just 0.65% above its 52-week low of Rs 40.05, underscoring the stock’s proximity to historic lows. The stock has been on a downward trajectory for the past two days, losing 4.52% over this period. This decline outpaced the broader Pesticides & Agrochemicals sector, where Meghmani underperformed by 2.6% on the day.
Comparing the stock’s performance against the Sensex reveals a stark contrast. Meghmani Organics declined 3.73% on the day, while the Sensex fell by a more modest 1.37%. Over longer time frames, the stock’s underperformance is even more pronounced. The one-month return stands at -23.61% versus the Sensex’s -8.66%, and over three months, Meghmani has lost 37.37% compared to the Sensex’s 12.70% decline. Year-to-date, the stock has dropped 37.39%, significantly lagging the Sensex’s 12.88% fall.
Long-Term Performance and Relative Benchmarking
Over the past year, Meghmani Organics has delivered a negative return of 34.94%, while the Sensex gained 4.33%. The stock has also underperformed the BSE500 index in each of the last three annual periods, highlighting a consistent trend of lagging behind broader market indices. Over three years, the stock has declined 47.33%, in stark contrast to the Sensex’s 28.77% gain. The five- and ten-year returns for Meghmani Organics remain at zero, while the Sensex has appreciated by 51.49% and 193.02%, respectively.
Technical Indicators and Trading Patterns
Technical analysis paints a bearish picture for Meghmani Organics. The stock is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. The overall technical trend is classified as bearish since 14 November 2025, when the stock was at ₹72.18. Key technical indicators such as MACD, Bollinger Bands, KST, and Dow Theory signal bearish momentum on both weekly and monthly timeframes. The immediate support level is near the 52-week low of ₹41.27, while resistance levels are identified at ₹45.79 (20-day moving average), ₹59.55 (100-day moving average), and ₹74.10 (200-day moving average).
Delivery volumes have shown an increase, with a 1-month delivery change of 87.33% and a 1-day delivery change of 12.64% compared to the 5-day average. On 25 March 2026, delivery volume was 7.98 lakh shares, representing 61.75% of total volume, higher than the trailing one-month average of 6.12 lakh shares.
Financial Performance and Profitability Metrics
Meghmani Organics’ financial metrics reveal several areas of concern. The company reported a quarterly PAT of Rs -3.53 crore, a decline of 135.6% compared to the previous four-quarter average. Interest expenses for the nine months ended have increased by 22.18% to Rs 71.38 crore, exerting pressure on profitability. The operating profit to interest ratio for the quarter is at a low 2.08 times, indicating limited coverage of interest obligations by operating earnings.
Operating profits have declined at a compound annual growth rate (CAGR) of -17.31% over the past five years. Return on Equity (ROE) averages 6.03%, signalling modest profitability relative to shareholders’ funds. Return on Capital Employed (ROCE) stands at 4.6%, reflecting subdued capital efficiency. Despite these challenges, the company maintains a relatively low debt-to-EBITDA ratio of 0.93 and moderate net debt to equity of 0.52, suggesting manageable leverage levels.
Valuation and Market Capitalisation
Meghmani Organics is classified as a small-cap company with a market capitalisation grade reflecting this status. The stock trades at a price-to-earnings (P/E) ratio of 26x on a trailing twelve-month basis and a price-to-book value (P/BV) of 0.69x, indicating it is valued below its book value. Enterprise value multiples include EV/EBITDA at 8.38x and EV/EBIT at 18.07x, while the EV to capital employed ratio is 0.80x, suggesting an attractive valuation relative to capital invested.
The PEG ratio is notably low at 0.14x, reflecting the relationship between price, earnings growth, and valuation. The stock’s dividend yield is not available, though the latest dividend declared was Rs 1.4 per share with an ex-dividend date of 20 June 2023. The dividend payout ratio remains unreported.
Quality Assessment and Institutional Holdings
The company’s overall quality grade is below average, based on long-term financial performance. Management risk, growth, and capital structure are all rated below average. Sales growth over five years is modest at 1.18%, while EBIT growth has contracted at -17.31%. The average EBIT to interest ratio is weak at -5.58x, though the company benefits from no promoter share pledging and a strong balance sheet.
Institutional ownership is limited, with domestic mutual funds holding only 0% of the company’s shares. This low institutional stake may reflect cautious positioning given the company’s recent performance and valuation metrics.
Summary of Key Financial Trends
Short-term financial trends remain negative as of December 2025. While the company reported a six-month PAT growth of 158.71% to Rs 8.02 crore and a highest half-year ROCE of 7.30%, quarterly results show a decline in PAT and operating profits. Net sales for the quarter were Rs 508.74 crore, the lowest in recent periods, with PBDIT at Rs 37.75 crore and profit before tax (excluding other income) at a loss of Rs 10.33 crore. Non-operating income accounted for 329.05% of profit before tax, indicating reliance on non-core income sources.
Conclusion
Meghmani Organics Ltd’s stock reaching an all-time low on 27 March 2026 reflects a culmination of sustained underperformance across multiple financial and technical parameters. The stock’s decline has been persistent over various time horizons, with significant underperformance relative to the Sensex and sector benchmarks. Financial indicators point to subdued profitability, rising interest costs, and weak growth trends. Technical signals remain bearish, with the stock trading below all major moving averages and near critical support levels. Valuation metrics suggest the stock is trading at a discount, yet quality assessments and institutional interest remain limited. This comprehensive data underscores the challenging environment faced by Meghmani Organics in the current market context.
